A Case of Castration-Resistant Prostate Cancer with Fatal Convulsive Seizure after Administration of Enzalutamide
Enzalutamide, an androgen receptor antagonist, is a standard drug for the treatment of castrationresistant prostate cancer. A 77-year-old man developed a seizure after administration of enzalutamide. The patient presented with general fatigue and high fever approximately 5 weeks after oral administr...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 63(2017), 10 vom: 05. Okt., Seite 431-433
|
1. Verfasser: |
Iwanishi, Toshichika
(VerfasserIn) |
Weitere Verfasser: |
Yumiba, Satoru,
Koida, Youhei,
Kobayashi, Masao,
Komori, Kazuhiko,
Ono, Yutaka |
Format: | Online-Aufsatz
|
Sprache: | Japanese |
Veröffentlicht: |
2017
|
Zugriff auf das übergeordnete Werk: | Hinyokika kiyo. Acta urologica Japonica
|
Schlagworte: | Case Reports
Journal Article
Review
Prostate cancer
Seizure
Benzamides
Nitriles
Phenylthiohydantoin
2010-15-3
enzalutamide
93T0T9GKNU |